June 30, 2011 Jerusalem, Israel The Israeli Chairmanship of EUREKA, the largest pan-European network for market-oriented, industrial R&D and innovation, has released new data from a report conducted by Kalman Gayer and the economic and strategic consulting firm Applied Economics Ltd., to mark the completion of Israel's Chairmanship year and EUREKA's 25th anniversary. The study presents the proven impact of EUREKA on companies participating in EUREKA programs.
Israel Shamay, Director of the Israeli Chairmanship of EUREKA, explained that the surveys previously conducted by various European R&D programs, including EUREKA, were based largely on interviews with managers and/or technical summary reports of the project, which naturally focused on the tools of R&D and less on financial results. "Since the Israeli Chairmanship does not consider industrial R&D an end in it of itself, but rather as a means to advance industry and economic growth through innovation and international cooperation, we decided to measure the financial effect of participation in the program for the firm."
Geyer's study measured the impact of participation in EUREKA projects for companies in Europe. The study is based on a sample of 350 companies which participated in EUREKA projects between 1996 and 2005. The study compares pairs of companies nearly identical in their parameters: size, country, field of technology, sales revenue, number of employees, etc. - with the key difference between them being that one company having participated in at least one EUREKA project, and the other company having not participated. The difference in outcomes (after the EUREKA project is completed) between the participating company and the non-participating company is attributed to the effect of participation in EUREKA. The research examined individual cooperation projects that were performed mostly by two partners from 2 countries, and that focused on industrial R&D - products close to mark
'/>"/>
| Contact: Piotr Pogorzelski piotr.pogorzelski@eurekanetwork.org 322-777-0979 EUREKA Source:Eurekalert |
Related biology news :
1. Georgia residents: Investment in global health research is vital to states economy
2. Life Sciences Venture Capital Investment Level Rebounds in Q1 2011 but Deal Volume Declines, According to the MoneyTree Report
3. Measuring science investments
4. President Obama calls for increased investment in science, including biomedical research
5. Stroz Friedberg Amplifying Growth with $115MM New Mountain Capital Investment
6. Stroz Friedberg Amplifying Growth with $115MM New Mountain Capital Investment
7. Wellcome-Wolfson partnership makes £30 million investment in UK scientific infrastructure
8. Endeavour to Present at Rodman & Renshaw Global Investment Conference
9. Caltech receives more than $33 million from American Recovery and Reinvestment Act
10. NASDCTEc and ACTE Ask the White House to Increase Investment in, Not Flat Fund, CTE
11. Iowa State faculty attract $4.8 million in American Recovery and Reinvestment Act grants
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |